Research

In 2013, the team from Overcoming Multiple Sclerosis (OMS) published a paper as part of the HOLISM research study in the International Journal of Neuroscience. This study showed that the consumption of...

A detailed look at the development of Innate Immunotherapeutics' potential Secondary Progressive MS treatment,...

The development of the International MS Genetics Consortium has led to the identification of more than 159 genetic variants that are associated with MS. However, we have to ask how important are these and are...

We recently conducted an interview with A/Prof An Goris (left) and Ph.D. student Kelly Hilven (right) from the Laboratory for Neuroimmunology at the University of Leuven in Belgium.  Earlier this year,...

A publication this week in BMJ Open has outlined a number of studies evaluating the use of stem cell therapy for people with progressive multiple sclerosis. These trials, being conducted by a team from...

The subject of progressive multifocal leukoencephalopathy (PML) has become very topical for people with multiple sclerosis, though it can still be quite confusing for many people. To help, we have prepared...

Neuropathic pain is a serious symptom experienced by many people with multiple sclerosis that can result in abnormal sensations (e.g. tingling and burning), spontaneous pain and increased sensitivity. Recent...

The fact that after puberty women get MS more than men indicates a potential role for female sex hormones in the development of the disease. The fact that this gender imbalance has increased over the past 50...

Due to the lack of available treatment options for people with secondary progressive multiple sclerosis (SPMS), the development of novel therapies is vitally important. We sat down with Simon Wilkinson (CEO,...

Fatigue is one of the most common symptoms associated with multiple sclerosis (MS) and is often the one that has the biggest impact on quality of life.  A new study from Dr Lauren Strober, a researcher at...